您正在瀏覽的是香港網站,香港證監會BJA907號,投資有風險,交易需謹慎
市場資訊

市場資訊

首頁市場資訊個股相關資訊

C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molec